Tag: Janssen Pharmaceutical

Janssen Covid‑19 vaccine gets conditional marketing authorization in EU

- March 27, 2021

The European Commission has granted a conditional marketing authorization (CMA) for the single dose Janssen Covid‑19 vaccine developed by the Janssen Pharmaceutical Companies of Johnson ... Read More

J&J Ad26.COV2.S COVID-19 vaccine gets FDA emergency use authorization

- February 28, 2021

Johnson & Johnson (J&J) said that the US Food and Drug Administration (FDA) has given emergency use authorization (EUA) for Ad26.COV2.S, a single-dose COVID-19 vaccine ... Read More

Janssen secures DARZALEX FASPRO FDA approval for AL amyloidosis

pharmanewsdaily- January 16, 2021

DARZALEX FASPRO FDA approval for AL amyloidosis : Janssen Pharmaceutical, a subsidiary of Johnson & Johnson, has secured approval from the US Food and Drug ... Read More

HMR59 : Janssen acquires rights to geographic atrophy treatment candidate from Hemera

pharmanewsdaily- December 3, 2020

Geographic atrophy treatment : Janssen Pharmaceuticals has signed a licensing deal to acquire rights to HMR59, an investigational gene therapy for geographic atrophy, from clinical ... Read More

Janssen seeks EMA’s expanded approval for DARZALEX in AL amyloidosis

pharmanewsdaily- November 8, 2020

The Janssen Pharmaceutical Companies of Johnson & Johnson has submitted a Type II variation application to the European Medicines Agency (EMA) seeking the expanded approval ... Read More

J&J begins phase 3 ENSEMBLE Covid-19 vaccine trial for JNJ-78436735

pharmanewsdaily- September 23, 2020

ENSEMBLE Covid-19 vaccine trial : Johnson & Johnson (J&J) has launched a multi-nation phase 3 trial called ENSEMBLE for its JNJ-78436735 Covid-19 vaccine candidate (Ad26.COV2.S), ... Read More

Janssen, Amgen secure FDA approval for DKd regiment in multiple myeloma

pharmanewsdaily- August 23, 2020

DKd regiment FDA approval for multiple myeloma : Janssen Pharmaceutical Companies of Johnson & Johnson and Amgen have been granted an expanded approval from the ... Read More

Nipocalimab developer Momenta Pharmaceuticals to be acquired by J&J

pharmanewsdaily- August 20, 2020

J&J acquisition of Momenta Pharmaceuticals : US healthcare giant Johnson & Johnson (J&J) has signed a $6.5 billion deal to acquire Momenta Pharmaceuticals, a biotech ... Read More

Janssen Covid-19 vaccine candidate Ad26.COV2.S bags $1bn deal from US govt

pharmanewsdaily- August 5, 2020

Johnson & Johnson (J&J) said that its subsidiary Janssen Pharmaceutical has agreed to manufacture and supply 100 million doses of its SARS-CoV-2 investigational vaccine Ad26.COV2.S ... Read More

Johnson & Johnson coronavirus vaccine targeted to be launched in early 2021

pharmanewsdaily- March 31, 2020

Johnson & Johnson said that it has selected a lead coronavirus vaccine candidate from constructs it has been working on since the start of this ... Read More